Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older, developed by Pfizer Canada ULC and BioNTech SE. The vaccine targets the Omicron LP.8.1 variant and will be available in pharmacies nationwide in the fall. BioNTech holds the Marketing Authorization for COMIRNATY in various countries. (RTTNews)

For more health news, visit rttnews.com. (RTTNews)

Read more at Nasdaq: Health Canada Authorizes Pfizer-BioNTech’s LP.8.1-Adapted COMIRNATY COVID-19 Vaccine